A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men

NCT01431079 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2013-02-04

Study results available
· View outcomes & findings →

Summary

The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health Belief Model to enhance HPV vaccine acceptability, and (3) test the efficacy of the above intervention based on the Health Belief Model by comparing it to a knowledge-based intervention. Approximately five focus groups with ten participants in each group with college students in the ages 18-25 years will be conducted at a large Midwestern University for the qualitative piece. Data will be analyzed for categories and triangulated with previous study to develop a theory based intervention. For the quantitative piece a randomized controlled design with 45 participants in each arm (theory based intervention and knowledge based intervention) will be implemented.

Conditions

  • HPV Vaccine Acceptability

Interventions

BEHAVIORAL

HPV vaccine acceptability

One arm will receive health belief model based educational intervention and other arm will receive knowledge-based educational intervention.

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Manoj Sharma, Ph.D. · University of Cincinnati

  • Rebecca Lee, Ph.D. · University of Cincinnati

  • Purvi Mehta, MS · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-07-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01431079 on ClinicalTrials.gov